NanoTYPE™ HLA-11 Plus
Experience the power of true full-gene HLA genotyping with NanoTYPETM HLA-11 Plus— covering all 11 classical loci from 5’UTR to 3’UTR. Seamlessly integrated with Oxford Nanopore TechnologiesTM (ONT) long-read platforms, it delivers uninterrupted phasing, fast library prep, and unambiguous results—even in highly polymorphic regions.
The Details
NanoTYPETM HLA-11 Plus: Full Coverage. Future Ready.
Our assay design spans from the 5’UTR to the 3’UTR, enabling full-gene phasing and precise, unambiguous allele assignment across the entire gene.
Simple, Fast and Accurate. Now with Full Gene Coverage.
Product Benefits
Software Analysis
Example of full phasing of DPB1*01:01:01:01 / 04:01:01:01
A dedicated visual panel showcases the Signal-to-Noise ratio and highlights allelic balance between chromosomes—delivering clarity and confidence in every result.
Full set of quality control metrics available for every HLA locus
NanoTYPER provides QC metrics per locus, including key exon minimum coverage, allele imbalance, spot noise ratio, and N50 read length. These metrics ensure transparent assessment of sequencing quality and genotyping reliability across all 11 HLA genes.
Product availability varies by region; please check with your local Werfen representative for regulatory status in your area. The product is CE-IVDR within the European Union.
Resource Library
PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.
Our Certifications
Related Products
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen Introduces NanoTYPE™ HLA-11 Plus CE— First CE-IVD HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes
Werfen, a global leader in specialized diagnostics, announced the availability of NanoTYPETM HLA-11 Plus as CE-IVD (according to IVD-R), a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes....
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary,...
News & Blogs
MIA FORATM NGS EXPRESS HLA Typing Software: You Spoke, We Listened!
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user...
News & Blogs
Coming Soon: Detect DP with LIFECODES® LifeScreen Deluxe!
Immucor is in the process of improving our LIFECODES® LifeScreen Deluxe (LMX) to add DP...
News & Blogs
CUSTOMER SPOTLIGHT: Mid-South Transplant Foundation, Inc. C3d Validation and Implementation
For all histocompatibility laboratories, Complement-Dependent Cytotoxicity (CDC) testing proves to be time consuming and tedious...
Experience Our Virtual Lab
Contact your sales representative for a personal tour.
